Certified by Founder Lodge 
                                        
                                        Umoja Biopharma
 
                                                 United States  -  Seattle, Washington 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $100,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2019
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patie
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| January, 21 ,2025 | Series C | $100,000,000 | 
                                                
 Alexandria Real Estate Equities, Inc.
                                                                                
 Qiming Venture Partners USA
                                                                                
 RTW Investments, LP
                                                                                
 DCVC Bio
                                                                                
 K2 HealthVentures
                                                                                
 MPM BioImpact
                                                                                
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)